MHRA Class 2 Medicines Recall: Metformin Hydrochloride 500mg/5ml Oral Solution (Rosemont Pharmaceuticals Limited)

MHRA Class 2 Medicines Recall: Metformin Hydrochloride 500mg/5ml Oral Solution (Rosemont Pharmaceuticals Limited)

August 25, 2021

Class 2 Medicines recall: Metformin Hydrochloride 500mg/5ml Oral Solution (Rosemont Pharmaceuticals Limited)

Drug alert number: EL (21) A/20

Date issued: 25th August 2021

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 2 medicines recall for:

Metformin Hydrochloride 500mg/5ml Oral Solution (Rosemont Pharmaceuticals Limited), PL 00427/0139

Rosemont Pharmaceuticals Limited is recalling all unexpired stock of the above product from pharmacies and wholesalers as a precautionary measure due to the identification level of an impurity above the acceptable limit. Following routine monitoring, the impurity, N-nitrosodimethylamine (NDMA) which has genotoxic and carcinogenic potential, has been observed at a level above the acceptable limit.

 

Batch Number Expiry Date Pack Size First Distributed
0LL0018 Nov 2021 150ml December 2020

Advice for healthcare professionals

  • Stop supplying the batches listed above immediately.
  • Quarantine all remaining stock and return it to your supplier using your supplier’s approved process.
  • Patients should be advised not to stop any treatments without consulting their relevant healthcare professional. The risks of suddenly stopping medication for type 2 diabetes is higher than the potential risk presented by the impurity.

Full drug alert can be viewed here.

Company contacts for further information

For stock control enquiries please contact: Customerservices@rosemontpharma.com For medical information enquiries please contact: pharmacovigilance@rosemontpharma.com

 



Posted in:


More Latest News >

PQS: AMS virtual event now on-demand

Community pharmacy contractors can now access an online recording of the antimicrobial stewardship (AMS) virtual event, which was jointly hosted...

Evaluation of LFD tests

As part of meeting Medicines and Healthcare products Regulatory Agency (MHRA) obligations, the UK Health Security Agency (UKHSA) – of...